Clinical trial
COPDGene Ancillary Proposal: Symbicort Intervention in "Airway Predominant
NCT01253473 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COPDGene Ancillary Proposal: Symbicort Intervention in "Airway Predominant
- Lead sponsor
- National Jewish Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- January 31, 2016
- Enrollment
- 46 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.